OverviewChartNewsTraderScreen

HSBC Knock-Out LLY/  DE000HS4ZKS0  /

Frankfurt Zert./HSBC
2024-08-09  9:35:47 PM Chg.+0.410 Bid9:57:14 PM Ask9:57:14 PM Underlying Strike price Expiration date Option type
1.500EUR +37.61% 1.530
Bid Size: 25,000		 1.560
Ask Size: 25,000		 Eli Lilly and Co 726.1606 USD 2078-12-31 Call
TeleTrader 08-08 US opens higher with data, earnings in focus
TeleTrader 08-08 Eli Lilly's Q2 revenue jumps 36% to $11.3B
TeleTrader 07-08 Eli Lilly launches $3.2B tender offer for Morphic
TeleTrader 07-02 US FDA approves Eli Lilly's Alzheimer's drug
GlobeNewswire 07-01 Ovid Therapeutics and Graviton Bioscience Announce Topline Data from a Phase 1 Clinical Trial Studyi...
GlobeNewswire 06-28 Atossa Therapeutics Announces Updated Protocol for Clinical Trial Evaluating (Z)-Endoxifen in Combin...
TeleTrader 06-25 Lilly partners with OpenAI to combat drug-resistance bacteria
GlobeNewswire 06-21 HUTCHMED Announces European Commission Approval for FRUZAQLA® (fruquintinib) Received by Takeda
GlobeNewswire 06-17 CytomX Therapeutics Promotes Chris Ogden to Chief Financial Officer
GlobeNewswire 06-17 Atossa Set to Join Russell 3000® Index Effective June 28, 2024
GlobeNewswire 06-14 TScan Therapeutics Announces Updates to its Board of Directors
GlobeNewswire 06-11 Global Multiple Sclerosis Drugs Market Size Projected to Reach $38 Billion By 2032 as Demand on R&D ...
TeleTrader 06-10 FDA advisors endorse Eli Lilly's Alzheimer's drug
GlobeNewswire 06-10 Sermonix Pharmaceuticals Announces Breast Cancer Research Publication of Paper Examining Lasofoxifen...
GlobeNewswire 06-06 Sermonix Pharmaceuticals Announces Chinese Approval of Investigational New Drug Application for Laso...
TeleTrader 06-05 Alphabet appoints Anat Ashkenazi as new CFO
GlobeNewswire 06-03 HUTCHMED Highlights Publication of Phase III FRUTIGA Results in Nature Medicine
GlobeNewswire 05-30 Sermonix Pharmaceuticals to Present Poster on ELAINE-3 Trial in Progress at ASCO 2024
GlobeNewswire 05-30 Anaqua Annual User Experience Conference to Feature Keynotes from Microsoft, SAP, USPTO, and More
GlobeNewswire 05-24 Gov. Holcomb Joins Lilly to Announce Additional $5.3 Billion Investment at LEAP District
TeleTrader 05-24 Eli Lilly to reveal $5.3B production boost
TeleTrader 05-21 Eli Lilly's diabetes drug receives authorization in China
GlobeNewswire 05-16 BeyondSpring R&D Day Highlights New Plinabulin Development Strategy for Cancer and Updates for SEED ...
GlobeNewswire 05-16 Totus Medicines Announces Strategic Multi-Target Research Collaboration with Lilly
GlobeNewswire 05-13 Atossa Therapeutics Announces First Quarter 2024 Financial Results and Provides Corporate Update